Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

ADTRAN Holdings Inc

AMC Networks

Bally's

Bread Financial Holdings Inc

Investors would do well to monitor stocks like ADTRAN (ADTN), Bread Financial (BFH), Owens & Minor (OMI), Bally's Corporation (BALY) and AMC Networks (AMCX) for high returns.

5 Stocks Loved by Brokers Worth Watching Currently

NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. (“OMI” or the “Company”) (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI

Owens & Minor, Inc. (NYSE:OMI ) Q2 2024 Earnings Conference Call August 2, 2024 8:30 AM ET Company Participants Jackie Marcus - IR Ed Pesicka - CEO Jon Leon - Interim CFO Conference Call Participants Michael Cherny - Leerink Partners Kevin Caliendo - UBS John Stansel - JPMorgan Stephanie Davis - Barclays Daniel Grosslight - Citi Eric Coldwell - Baird Operator Good day, and thank you for standing by. Welcome to the Owens & Minor Second Quarter 2024 Earnings Conference Call.

Owens & Minor, Inc. (OMI) Q2 2024 Earnings Call Transcript

LOS ANGELES , Aug. 2, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE: OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

OMI Investors Have Opportunity to Join Owens & Minor, Inc. Fraud Investigation with the Schall Law Firm

Owens & Minor (OMI) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.18 per share a year ago.

Owens & Minor (OMI) Q2 Earnings and Revenues Surpass Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the second quarter, representing year-over-year growth of 4% Net loss of $(32) million or $(0.42) per share in the second quarter Adjusted EBITDA of $127 million in the second quarter, representing year-over-year growth of 12% Doubled second quarter year over year Adjusted earnings per share from.

Owens & Minor Reports Second Quarter 2024 Financial Results

NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI

NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor, Inc. (OMI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESSWIRE / July 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor, Inc. (OMI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Owens & Minor (OMI) Beat Estimates Again in Its Next Earnings Report?

Owens & Minor (OMI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?

The consensus price target hints at a 29.5% upside potential for Owens & Minor (OMI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Believe Owens & Minor (OMI) Could Rally 29.48%: Here's is How to Trade

NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

OMI ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Owens & Minor, Inc. Investment

Albany International

AMN Healthcare Services

Barnes Group

TopBuild

Boot Barn Hlds

Cohu

The Russell 2000 had a rally for the ages, but shares of some smaller companies still look attractive.

7 Small-Cap Stocks to Buy After the Easy Money's Been Made

Owens & Minor (OMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Owens & Minor (OMI) Stock Jumps 7.6%: Will It Continue to Soar?

Owens & Minor, Inc. (NYSE:OMI ) Special Conference Call July 23, 2024 8:30 AM ET Company Participants Jacqueline Marcus - Investor Relations, Alpha IR Group Edward Pesicka - President and Chief Executive Office Jonathan A. Leon - Interim CFO and SVP of Finance and Corporate Treasurer Conference Call Participants Stephanie Davis - Barclays John Stansel - JP Morgan Daniel Clark - Leerink Partners Allen Lutz - Bank of America Operator Greetings, welcome to Owens & Minor Special Conference Call to discuss its proposed acquisition of Rotech Healthcare Holdings, Inc. At this time, all participants are in a listen-only mode.

Owens & Minor, Inc. (OMI) Special Conference Call (Transcript)

NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

ATTENTION Owens & Minor, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

Medical supplies distributor Owens & Minor said on Tuesday it has agreed to buy medical equipment firm Rotech Healthcare for $1.36 billion in cash to expand its presence in home-based care.

Owens & Minor to buy medical equipment firm Rotech for $1.36 bln

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference call. Selected Preliminary Financial Results for the Quarter Ended June 30, 2024 (1)   ($ in millions, except per share data)   2Q24     Revenue $2,651 - $2,6.

Owens & Minor, Inc. Releases Preliminary Second Quarter 2024 Financial Results & Reaffirms 2024 Annual Guidance

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (“Rotech”), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple.

Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healthcare Holdings, Inc. for $1.36 Billion in Cash

NEW YORK, NY / ACCESSWIRE / July 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Owens & Minor, Inc. (OMI)

NEW YORK, NY / ACCESSWIRE / July 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

OMI ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Owens & Minor, Inc. Investment

Crossfirst Bankshares Inc

Reddit Inc

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 40 points on Tuesday.

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Levi & Korsinsky Announces an Investigation on Behalf of Owens & Minor, Inc. (OMI) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

News for Owens & Minor Stock (OMI)